Neurocrine Biosciences (NasdaqGS:NBIX) presented new long term clinical data for CRENESSITY in classic congenital adrenal ...
Earlier in June 2026, Neurocrine Biosciences reported new Phase 3 and real‑world data at ENDO 2026 showing CRENESSITY ...
For Lower Queen Anne, the swap sets up a familiar Seattle balancing act. Neighbors and city planners will be weighing several ...
Submission based on results of APEX pivotal trial which demonstrated bezuclastinib objective response rate (CR+CRh+PR+CI) of 65% per mIWG ...
Satellos Bioscience's shares jumped Monday after the Duchenne treatment being developed by the biotechnology company received fast track designation in the U.S. In morning trading, the shares rose 12% ...
SAT-3247 has now received FDA Fast Track, Orphan Drug and Rare Pediatric Disease designations for Duchenne muscular dystrophy ("Duchenne" or "DMD")Fast Track is designed to expedite the development/re ...
First consumer health product positions Daré for revenue generation while expanding its women's health leadership platformAccess the segment ...
An analysis of antitrust-related reverse break-up fees in recent public merger and private acquisition agreements, including ...
The National Growth Fund will make equity investments of 500 billion won ($325 million) each in biotech firm LigaChem ...
Eating vitamin D-rich foods can help improve calcium absorption in the gut and its deposition into bones. Prebiotics and probiotics may also help with calcium absorption by promoting healthy gut ...
Introduction In the past five decades, Afghanistan has experienced one of the world’s largest and most protracted displacement crises. Stressors experienced during the pre-migration, transit and ...
Chinese biopharma stocks rallied on Monday, as investors moved away from artificial-intelligence stocks amid concerns over overstretched valuations. Shares of BeOne Medicines led gains among biopharma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results